PHASE Scientific Americas Announces Continued Growth with Investment of a New CLIA-Certified Medical LaboratoryPress Release
July 26, 2023
PHASE Scientific Americas Announces Continued Growth with Investment of a New CLIA-Certified Medical Laboratory, PHASE lab.
(GARDEN GROVE, CA) — July 26, 2023 — PHASE Scientific Americas (PHASE Scientific), a fast-growing biotechnology company actively developing innovative solutions to revolutionize diagnostics in healthcare announces that their PHASE Scientific Medical Laboratory (PHASE Lab) has been certified by Clinical Laboratory Improvement Amendments (CLIA) and issued licensure by the California Department of Public Health (CDPH) to perform moderate and high-complexity testing.
CLIA certification is based on a Quality Management System framework that ensures high quality throughout the testing process, focusing on personnel qualification and competency, laboratory facilities, laboratory operations, quality control and quality assurance programs. PHASE Lab has demonstrated that it operates in a manner that ensures high-quality standards in patient testing.
PHASE Lab is a 16,000+ SF facility located in Irvine, California, equipped with state-of-the-art molecular diagnostic and sequencing capabilities and led by healthcare and lab veterans with deep experience in infectious disease and oncology among other areas of specialty. PHASE Scientific’s investment in the laboratory facility will enable the company to launch at-home testing services and professional oncology services.
PHASE Scientific’s diagnostics solutions promote early detection of diseases and infections, by providing faster access to treatment and efficient delivery of results to patients and providers. PHASE Scientific is one of the leaders in at-home rapid tests with its INDICAID COVID-19 Rapid Antigen At-Home Test and upcoming line of rapid antigen and At-Home Testing Services.
Looking forward, PHASE Lab intends to make use its proprietary technology, PHASIFY, that leverages liquid phase extraction to improve the sensitivity and efficiency of diagnostics in healthcare, particularly in the areas of liquid biopsy, infectious diseases, and cancer detection.
“PHASE’s mission is to continue to shape the future of at-home, personal diagnostics care with people-first, science-based innovations. Our investment with PHASE Lab is just one example of how we are continuing to innovate as we develop the most valuable tools for the future of diagnostics testing,” said Felix Chao, General Manager of PHASE Scientific Americas. “We are excited to grow and position PHASE to bring tremendous value to the diagnostic testing market.”
About PHASE Scientific
PHASE Scientific Americas is a fast growing biotechnology company with a mission to inspire a new state of health. We are committed to providing patients and healthcare providers in the Americas and beyond with innovative diagnostic and data tools that will enable them to access better health information and make better health decisions. An affiliate of PHASE Scientific International, headquartered in Hong Kong, we have strategic offices in Garden Grove, California and Atlanta, Georgia.
More Related News
PHASE Scientific Americas Announces INDICAID Health™ At-Home Test Kits and Digital Health Platform
October 25, 2023